Half a year after President Biden officially directed federal agencies in the executive branch’s bailiwick to “seize the promise and manage the risks” of AI, the White House has posted a status report.

UnitedHealth CEO Andrew Witty told the Senate Finance Committee that systems have been rebuilt “from scratch” in light of the oversight.

Medtronic brand SonarMed airway monitors and acoustic sensors are being recalled due to a risk of breathing obstruction and lung tissue damage.

U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned? 

The litigation stems from a 2023 recall of CPAP machines and ventilators that caused users to inhale pieces of foam during use. The faulty units were linked to at least 561 deaths.

The healthcare employers’ trade group said a nationwide ban on noncompete contracts will stifle investment in new technologies.

Tracking technologies sent patient information to advertisers such as Microsoft, Google and Meta.

InfuTronix has received 3,698 complaints related to device failures of its Halo Ambulatory Infusion system and other Nimbus pumps.